Cite

    Hudert, C. et al. (2022). Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17‐beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms. Hepatology communications. 6 (8), pp. 1934-1948. [Online].